Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling

Hepatology

Volumn 42, Issue 4, 2005, Pages 809-818

  Nam, Suk Woo ^a   Park, Jik Young ^a   Ramasamy, Adaikalavan ^b   Shevade, Shirish ^b   Islam, Amirul ^b   Long, Philip M ^b   Park, Cheol Keun ^c   Park, Soo Eun ^a   Kim, Su Young ^a   Lee, Sug Hyung ^a   Park, Won Sang ^a   Yoo, Nam Jin ^a   Liu, Edison T ^b   Miller, Lance D ^b   Lee, Jung Young ^a  

^a The Catholic University of Korea   (South Korea)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; DIAGONAL LINEAR DISCRIMINANT ANALYSIS; DISCRIMINANT ANALYSIS; DNA MICROARRAY; DYSPLASIA; DYSPLASTIC LIVER NODULE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE VECTOR; GENETIC TRANSCRIPTION; HIGH GRADE DYSPLASTIC NODULE; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER NODULE; LOW GRADE DYSPLASTIC NODULE; PRIORITY JOURNAL; SUPPORT VECTOR MACHINE; TUMOR CLASSIFICATION; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS;

EID: 25844461787     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20878     Document Type: Article

References (37)

1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepato cellular carcinoma. Nat Genet 2002;31:339-346.
2. Pang A, Ng IO. Fan SI, Kwong YL. Clinicopathologic significance of generic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 2003;146:8-15.
3. de La CA, Komagnolo R. Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the betacatenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Nail Acad Sci U S A 1998;95: 8847-8851.
4. Satoh S, Daigo Y, Furukawa Y, Karo T, Miwa N, Nishiwaki T, et al. AXIN1 mutations in hepatocellular carcinomas, and growrh suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000;24: 245-250.
5. Takayama T, Makuuchi M, Hirohashi S, Sakamout M, Okazaki N, Takayasu K, et al. Malignant transformation of adenomarous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-1153.
6. Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin liver Dis 2002;6:497-512.
7. Terminology of nodular hepatocellular lesions. International Working Party. HEPATOLOGY 1995;22:983-993.
8. Tornillo L, Carafa V, Sauter G, Moch H, Minola E, Gambacorra M, et al. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 2002;82:547-553.
9. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepato carcinogenesis: adenomaous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178.
10. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810-819.
11. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. HEPATOLOGY 1998;28:1241-1246.
12. Kojiro M. Premalignam lesions of hepatocellular carcinoma: pathologic viewpoint. J Hepatobiliary Pancreat Surg 2000;7:535-541.
13. Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002;6:497-512.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
15. Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakamuna Y. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993;17:1113-1123.
16. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocelltilar carcinoma (HCC) to tumor size and demonstration of tumor cells of multiple different grades in single small HCC. Liver 1987; 7:18-26.
17. Chen X, Chenng ST, So S, Fan ST, Barry C, Higgins J. et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-1939.
18. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, et al. Insight into hepatocellular carcinogencsis u transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncaucerous liver, Proc Natl Acad Sci U S A 2001;98:15089-15094.
19. Okahe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis or gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-2137.
20. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma hy gene expression profiling. HEPATOLOGY 2004;40:667-676.
21. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 1999;303:179-205.
22. DeRisi JL, lyer VK, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997;278:680-686.
23. Eisen MB, Spellman PT, Brown PO, Botstein D, Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
24. Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A 2000;97:262-267.
25. Furey TS, Crisuanini N, Duffy N, Bednarskil DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16:906-914.
26. Ramaswamy S, Tamayo P, Rilkin R, Mukherjee S, Yeang CH, Angelo M, et al. Muhiclass cancer diagnosis using tumor gene expression signanures. Proc Nad Acad Sci U S A 2001;98:15149-15154.
27. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000.
28. Troyanskaya O, Camor M, Sherlock C, Brown P, Hastie T, Tihshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001;17:520-525.
29. Kim I, Kang HC, Park J. Microarray application in cancer research. Cancer Research and Treatment 2004;36:207-213.
30. Kojiro M. Pathology of early hepatocellular carcinoma: progression from early to advanced. Hepatogastroenterology 1998;45(Suppl 3):1203-1205.
31. Kojiro M, Yano H, Nakashima O. Pathology of early hepatocellular carcinoma: progression from early to advanced. Semin Surg Oncol 1996;12: 197-203.
32. Huang SL, Shyu KY, Yeh MY, Jiang SY. The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res 2002;22:799-804.
33. Casanova B, de la Fuente MT, Garcia-Gila M, Sanz L, Silva A, Garcia-Marco JA, Garcia-Pardo A. The class II minor-suppressor gene KARRKS3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression. Leukemia 2001;15:1521-1526.
34. Shyn RY, Jiang SY, Chou JM, Shih YL, Lee MS, Yu JC, et al. RARRES3 expression positively correlated to rumour differenation in tissues of colorectal adenocarcinoma. Br J Cancer 2003;89:146-151.
35. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, et al. Gene-expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-1939.
36. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003;37:198-207.
37. Lev JS, Chu IS, Heo J, Calvisi DL, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. HEPATOLOGY 2004;40:667-676.